News

New Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
MedPage Today on MSN19h
Novel Oral Agent for ESR1-Mutated Breast Cancer Boosts PFS in Second-Line
The investigational oral agent vepdegestrant more than doubled median progression-free survival (PFS) versus fulvestrant ...
The Manila Times11h
New data show Roche's Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...